Th1/17 polarization of CD4 T cells supports HIV-1 persistence during antiretroviral therapy

Journal of Virology

Volumn 89, Issue 22, 2015, Pages 11284-11293

  Sun, Hong ^a,b   Kim, Dhohyung ^a   Li, Xiaodong ^a   Kiselinova, Maja ^a,c   Ouyang, Zhengyu ^a   Vandekerckhove, Linos ^c   Shang, Hong ^b   Rosenberg, Eric S ^d   Yu, Xu G ^a   Lichterfeld, Mathias ^a,d,e  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b CHINA MEDICAL UNIVERSITY   (China)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; VIRUS DNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; CD4 T MEMORY CELL; CD4+ T LYMPHOCYTE; CELL SHAPE; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION SENSITIVITY; MALE; MEMORY T LYMPHOCYTE; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; CD4 LYMPHOCYTE COUNT; CELL CULTURE; CELL POLARITY; DNA SEQUENCE; GENETICS; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MIDDLE AGED; NUCLEOTIDE SEQUENCE; TH2 CELL; VIROLOGY; VIRUS LATENCY; VIRUS REPLICATION;

ADULT; ANTI-HIV AGENTS; BASE SEQUENCE; CD4 LYMPHOCYTE COUNT; CELL POLARITY; CELLS, CULTURED; DNA, VIRAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; SEQUENCE ANALYSIS, DNA; TH1 CELLS; TH17 CELLS; TH2 CELLS; VIRUS LATENCY; VIRUS REPLICATION;

EID: 84945908849     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01595-15     Document Type: Article

References (47)

1. Coiras M, Lopez-Huertas MR, Perez-Olmeda M, Alcami J. 2009. Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs. Nat Rev Microbiol 7:798-812. http://dx.doi.org/10.1038/nrmicro2223.
2. Eisele E, Siliciano RF. 2012. Redefining the viral reservoirs that prevent HIV-1 eradication. Immunity 37:377-388. http://dx.doi.org/10.1016/j.immuni.2012.08.010.
3. Katlama C, Deeks SG, Autran B, Martinez-Picado J, van Lunzen J, Rouzioux C, Miller M, Vella S, Schmitz JE, Ahlers J, Richman DD, Sekaly RP. 2013. Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs. Lancet 381:2109-2117. http://dx.doi.org/10.1016/S0140-6736(13)60104-X.
4. Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, Quinn TC, Chadwick K, Margolick J, Brookmeyer R, Gallant J, Markowitz M, Ho DD, Richman DD, Siliciano RF. 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295-1300. http://dx.doi.org/10.1126/science.278.5341.1295.
5. Siliciano JD, Kajdas J, Finzi D, Quinn TC, Chadwick K, Margolick JB, Kovacs C, Gange SJ, Siliciano RF. 2003. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med 9:727-728. http://dx.doi.org/10.1038/nm880.
6. Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio FA, Yassine-Diab B, Boucher G, Boulassel MR, Ghattas G, Brenchley JM, Schacker TW, Hill BJ, Douek DC, Routy JP, Haddad EK, Sekaly RP. 2009. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 15:893-900. http://dx.doi.org/10.1038/nm.1972.
7. Buzon MJ, Sun H, Li C, Shaw A, Seiss K, Ouyang Z, Martin-Gayo E, Leng J, Henrich TJ, Li JZ, Pereyra F, Zurakowski R, Walker BD, Rosenberg ES, Yu XG, Lichterfeld M. 2014. HIV-1 persistence in CD4+ T cells with stem cell-like properties. Nat Med 20:139-142. http://dx.doi.org/10.1038/nm.3445.
8. Jaafoura S, de Goer de Herve MG, Hernandez-Vargas EA, Hendel-Chavez H, Abdoh M, Mateo MC, Krzysiek R, Merad M, Seng R, Tardieu M, Delfraissy JF, Goujard C, Taoufik Y. 2014. Progressive contraction of the latent HIV reservoir around a core of less-differentiated CD4(+) memory T Cells. Nat Commun 5:5407. http://dx.doi.org/10.1038/ncomms6407.
9. Cartwright EK, McGary CS, Cervasi B, Micci L, Lawson B, Elliott ST, Collman RG, Bosinger SE, Paiardini M, Vanderford TH, Chahroudi A, Silvestri G. 2014. Divergent CD4+ T memory stem cell dynamics in pathogenic and nonpathogenic simian immunodeficiency virus infections. J Immunol 192:4666-4673. http://dx.doi.org/10.4049/jimmunol.1303193.
10. Klatt NR, Bosinger SE, Peck M, Richert-Spuhler LE, Heigele A, Gile JP, Patel N, Taaffe J, Julg B, Camerini D, Torti C, Martin JN, Deeks SG, Sinclair E, Hecht FM, Lederman MM, Paiardini M, KirchhoffF, Brenchley JM, Hunt PW, Silvestri G. 2014. Limited HIV infection of central memory and stem cell memory CD4+ T cells is associated with lack of progression in viremic individuals. PLoS Pathog 10:e1004345. http://dx.doi.org/10.1371/journal.ppat.1004345.
11. Farber DL, Yudanin NA, Restifo NP. 2014. Human memory T cells: generation, compartmentalization and homeostasis. Nat Rev Immunol 14:24-35. http://dx.doi.org/10.1038/nri3567.
12. Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, Quigley MF, Almeida JR, Gostick E, Yu Z, Carpenito C, Wang E, Douek DC, Price DA, June CH, Marincola FM, Roederer M, Restifo NP. 2011. A human memory T cell subset with stem cell-like properties. Nat Med 17:1290-1297. http://dx.doi.org/10.1038/nm.2446.
13. Gattinoni L, Zhong XS, Palmer DC, Ji Y, Hinrichs CS, Yu Z, Wrzesinski C, Boni A, Cassard L, Garvin LM, Paulos CM, Muranski P, Restifo NP. 2009. Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells. Nat Med 15:808-813. http://dx.doi.org/10.1038/nm.1982.
14. Lugli E, Dominguez MH, Gattinoni L, Chattopadhyay PK, Bolton DL, Song K, Klatt NR, Brenchley JM, Vaccari M, Gostick E, Price DA, Waldmann TA, Restifo NP, Franchini G, Roederer M. 2013. Superior T memory stem cell persistence supports long-lived T cell memory. J Clin Invest 123:594-599. http://dx.doi.org/10.1172/JCI66327.
15. Lugli E, Gattinoni L, Roberto A, Mavilio D, Price DA, Restifo NP, Roederer M. 2013. Identification, isolation and in vitro expansion of human and nonhuman primate T stem cell memory cells. Nat Protoc 8:33-42. http://dx.doi.org/10.1038/nprot.2012.143.
16. Zhu J, Yamane H, Paul WE. 2010. Differentiation of effector CD4 T cell populations. Annu Rev Immunol 28:445-489. http://dx.doi.org/10.1146/annurev-immunol-030409-101212.
17. Zhu J, Paul WE. 2008. CD4 T cells: fates, functions, and faults. Blood 112:1557-1569. http://dx.doi.org/10.1182/blood-2008-05-078154.
18. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655-669. http://dx.doi.org/10.1016/S0092-8674(00)80702-3.
19. Zheng W, Flavell RA. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89: 587-596. http://dx.doi.org/10.1016/S0092-8674(00)80240-8.
20. Stockinger B, Veldhoen M, Martin B. 2007. Th17 T cells: linking innate and adaptive immunity. Semin Immunol 19:353-361. http://dx.doi.org/10.1016/j.smim.2007.10.008.
21. Dong C. 2008. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 8:337-348. http://dx.doi.org/10.1038/nri2295.
22. Tangye SG, Ma CS, Brink R, Deenick EK. 2013. The good, the bad and the ugly-TFH cells in human health and disease. Nat Rev Immunol 13: 412-426. http://dx.doi.org/10.1038/nri3447.
23. Hale JS, Ahmed R. 2015. Memory T follicular helper CD4 T cells. Front Immunol 6:16. http://dx.doi.org/10.3389/fimmu.2015.00016.
24. Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G, Foucat E, Dullaers M, Oh S, Sabzghabaei N, Lavecchio EM, Punaro M, Pascual V, Banchereau J, Ueno H. 2011. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 34:108-121. http://dx.doi.org/10.1016/j.immuni.2010.12.012.
25. Muranski P, Borman ZA, Kerkar SP, KlebanoffCA, Ji Y, Sanchez-Perez L, Sukumar M, Reger RN, Yu Z, Kern SJ, Roychoudhuri R, Ferreyra GA, Shen W, Durum SK, Feigenbaum L, Palmer DC, Antony PA, Chan CC, Laurence A, Danner RL, Gattinoni L, Restifo NP. 2011. Th17 cells are long lived and retain a stem cell-like molecular signature. Immunity 35:972-985. http://dx.doi.org/10.1016/j.immuni.2011.09.019.
26. Kryczek I, Zhao E, Liu Y, Wang Y, Vatan L, Szeliga W, Moyer J, Klimczak A, Lange A, Zou W. 2011. Human TH17 cells are long-lived effector memory cells. Sci Transl Med 3:104ra100. http://dx.doi.org/10.1126/scitranslmed.3002949.
27. Josefsson L, Eriksson S, Sinclair E, Ho T, Killian M, Epling L, Shao W, Lewis B, Bacchetti P, Loeb L, Custer J, Poole L, Hecht FM, Palmer S. 2012. Hematopoietic precursor cells isolated from patients on long-term suppressive HIV therapy did not contain HIV-1 DNA. J Infect Dis 206: 28-34. http://dx.doi.org/10.1093/infdis/jis301.
28. Sharkey M, Babic DZ, Greenough T, Gulick R, Kuritzkes DR, Stevenson M. 2011. Episomal viral cDNAs identify a reservoir that fuels viral rebound after treatment interruption and that contributes to treatment failure. PLoS Pathog 7:e1001303. http://dx.doi.org/10.1371/journal.ppat.1001303.
29. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24:1596-1599. http://dx.doi.org/10.1093/molbev/msm092.
30. Gosselin A, Monteiro P, Chomont N, Diaz-Griffero F, Said EA, Fonseca S, Wacleche V, El-Far M, Boulassel MR, Routy JP, Sekaly RP, Ancuta P. 2010. Peripheral blood CCR4+CCR6+ and CXCR3+CCR6+CD4+ T cells are highly permissive to HIV-1 infection. J Immunol 184:1604-1616. http://dx.doi.org/10.4049/jimmunol.0903058.
31. Locci M, Havenar-Daughton C, Landais E, Wu J, Kroenke MA, Arlehamn CL, Su LF, Cubas R, Davis MM, Sette A, Haddad EK, International AIDS Vaccine Initiative Protocol C Principal Investigators, Poignard P, Crotty S. 2013. Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity 39:758-769. http://dx.doi.org/10.1016/j.immuni.2013.08.031.
32. He J, Tsai LM, Leong YA, Hu X, Ma CS, Chevalier N, Sun X, Vandenberg K, Rockman S, Ding Y, Zhu L, Wei W, Wang C, Karnowski A, Belz GT, Ghali JR, Cook MC, Riminton DS, Veillette A, Schwartzberg PL, Mackay F, Brink R, Tangye SG, Vinuesa CG, Mackay CR, Li Z, Yu D. 2013. Circulating precursor CCR7(lo)PD-1(hi) CXCR5(+) CD4(+) T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity 39:770-781. http://dx.doi.org/10.1016/j.immuni.2013.09.007.
33. El Hed A, Khaitan A, Kozhaya L, Manel N, Daskalakis D, Borkowsky W, Valentine F, Littman DR, Unutmaz D. 2010. Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection. J Infect Dis 201:843-854. http://dx.doi.org/10.1086/651021.
34. Muranski P, Restifo NP. 2013. Essentials of Th17 cell commitment and plasticity. Blood 121:2402-2414. http://dx.doi.org/10.1182/blood-2012-09-378653.
35. Bernier A, Cleret-Buhot A, Zhang Y, Goulet JP, Monteiro P, Gosselin A, DaFonseca S, Wacleche VS, Jenabian MA, Routy JP, Tremblay C, Ancuta P. 2013. Transcriptional profiling reveals molecular signatures associated with HIV permissiveness in Th1Th17 cells and identifies peroxisome proliferator-activated receptor gamma as an intrinsic negative regulator of viral replication. Retrovirology 10:160. http://dx.doi.org/10.1186/1742-4690-10-160.
36. Monteiro P, Gosselin A, Wacleche VS, El-Far M, Said EA, Kared H, Grandvaux N, Boulassel MR, Routy JP, Ancuta P. 2011. Memory CCR6+CD4+ T cells are preferential targets for productive HIV type 1 infection regardless of their expression of integrin beta7. J Immunol 186: 4618-4630. http://dx.doi.org/10.4049/jimmunol.1004151.
37. Alvarez Y, Tuen M, Shen G, Nawaz F, Arthos J, WolffMJ, Poles MA, Hioe CE. 2013. Preferential HIV infection of CCR6+ Th17 cells is associated with higher levels of virus receptor expression and lack of CCR5 ligands. J Virol 87:10843-10854. http://dx.doi.org/10.1128/JVI.01838-13.
38. Pepper M, Linehan JL, Pagan AJ, Zell T, Dileepan T, Cleary PP, Jenkins MK. 2010. Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat Immunol 11:83-89. http://dx.doi.org/10.1038/ni.1826.
39. Lee YK, Turner H, Maynard CL, Oliver JR, Chen D, Elson CO, Weaver CT. 2009. Late developmental plasticity in the T helper 17 lineage. Immunity 30:92-107. http://dx.doi.org/10.1016/j.immuni.2008.11.005.
40. Bending D, De la Pena H, Veldhoen M, Phillips JM, Uyttenhove C, Stockinger B, Cooke A. 2009. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest 119:565-572. http://dx.doi.org/10.1172/JCI37865.
41. Cohn LB, Silva IT, Oliveira TY, Rosales RA, Parrish EH, Learn GH, Hahn BH, Czartoski JL, McElrath MJ, Lehmann C, Klein F, Caskey M, Walker BD, Siliciano JD, Siliciano RF, Jankovic M, Nussenzweig MC. 2015. HIV-1 integration landscape during latent and active infection. Cell 160:420-432. http://dx.doi.org/10.1016/j.cell.2015.01.020.
42. Maldarelli F, Wu X, Su L, Simonetti FR, Shao W, Hill S, Spindler J, Ferris AL, Mellors JW, Kearney MF, Coffin JM, Hughes SH. 2014. HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells. Science 345:179-183. http://dx.doi.org/10.1126/science.1254194.
43. Boswell KL, Paris R, Boritz E, Ambrozak D, Yamamoto T, Darko S, Wloka K, Wheatley A, Narpala S, McDermott A, Roederer M, Haubrich R, Connors M, Ake J, Douek DC, Kim J, Petrovas C, Koup RA. 2014. Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection. PLoS Pathog 10:e1003853. http://dx.doi.org/10.1371/journal.ppat.1003853.
44. Perreau M, Savoye AL, De Crignis E, Corpataux JM, Cubas R, Haddad EK, De Leval L, Graziosi C, Pantaleo G. 2013. Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. J Exp Med 210:143-156. http://dx.doi.org/10.1084/jem.20121932.
45. Yang Z, Engel JD. 1993. Human T cell transcription factor GATA-3 stimulates HIV-1 expression. Nucleic Acids Res 21:2831-2836. http://dx.doi.org/10.1093/nar/21.12.2831.
46. Baron BW, Desai M, Baber LJ, Paras L, Zhang Q, Sadhu A, Duguay S, Nucifora G, McKeithan TW, Zeleznik-Le N. 1997. BCL6 can repress transcription from the human immunodeficiency virus type I promoter/enhancer region. Genes Chromosomes Cancer 19:14-21.
47. Holmes D, Knudsen G, Mackey-Cushman S, Su L. 2007. FoxP3 enhances HIV-1 gene expression by modulating NFkappaB occupancy at the long terminal repeat in human T cells. J Biol Chem 282:15973-15980. http://dx.doi.org/10.1074/jbc. M702051200.